Viewing Study NCT01901692


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2026-02-26 @ 12:42 AM
Study NCT ID: NCT01901692
Status: COMPLETED
Last Update Posted: 2017-09-18
First Post: 2013-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion
Sponsor: Asan Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None liver cancer View
None first-line View
None tumor thrombus View
None vascular invasion View